{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T17:53:04Z","timestamp":1714240384913},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,10,4]],"date-time":"2015-10-04T00:00:00Z","timestamp":1443916800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s00108-015-3704-1","type":"journal-article","created":{"date-parts":[[2015,10,2]],"date-time":"2015-10-02T06:33:12Z","timestamp":1443767592000},"page":"1271-1276","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Resistenz bei Pilzen"],"prefix":"10.1007","volume":"56","author":[{"given":"M.J.G.T.","family":"Vehreschild","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.A.","family":"Cornely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,4]]},"reference":[{"key":"3704_CR1","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00277-014-2108-y","volume":"93","author":"Tacke","year":"2014","unstructured":"Tacke D, Buchheidt D, Karthaus M et\u00a0al (2014) Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology. Ann Hematol 93:1449\u20131456","journal-title":"Ann Hematol"},{"key":"3704_CR2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","volume":"18","author":"Cornely","year":"2012","unstructured":"Cornely OA, Bassetti M, Calandra T et\u00a0al (2012) ESCMID guideline for the diagnosis and management of candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect 18(Suppl\u00a07):19\u201337","journal-title":"Clin Microbiol Infect"},{"key":"3704_CR3","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/cid\/civ293","volume":"61","author":"Cornely","year":"2015","unstructured":"Cornely OA, Gachot B, Akan H et\u00a0al (2015) Epidemiology and outcome of fungemia in a cancer cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC\u00a065031). Clin Infect Dis 61(3):324\u2013331","journal-title":"Clin Infect Dis"},{"key":"3704_CR4","doi-asserted-by":"crossref","first-page":"7601","DOI":"10.1128\/AAC.04134-14","volume":"58","author":"Shields","year":"2014","unstructured":"Shields RK, Nguyen MH, Press EG, Clancy\u00a0CJ (2014) Abdominal candidiasis is a hidden reservoir of echinocandin resistance. Antimicrob Agents Chemother 58:7601\u20137605","journal-title":"Antimicrob Agents Chemother"},{"key":"3704_CR5","doi-asserted-by":"crossref","unstructured":"Reboli AC, Rotstein C, Pappas PG et\u00a0al (2007) Anidulafungin versus fluconazole for invasive candidiasis. N\u00a0Engl J Med 356:2472\u20132482","DOI":"10.1056\/NEJMoa066906"},{"key":"3704_CR6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/1469-0691.12038","volume":"18","author":"Cuenca-Estrella","year":"2012","unstructured":"Cuenca-Estrella M, Verweij PE, Arendrup MC et\u00a0al (2012) ESCMID guideline for the diagnosis and management of candida diseases 2012: diagnostic procedures. Clin Microbiol Infect 18(Suppl\u00a07):9\u201318","journal-title":"Clin Microbiol Infect"},{"key":"3704_CR7","doi-asserted-by":"crossref","unstructured":"Steinbach WJ, Marr KA, Anaissie EJ et\u00a0al (2012) Clinical epidemiology of 960\u00a0patients with invasive aspergillosis from the PATH Alliance registry. J\u00a0Infect 65:453\u2013464","DOI":"10.1016\/j.jinf.2012.08.003"},{"key":"3704_CR8","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3324\/haematol.2009.012054","volume":"95","author":"Pagano","year":"2010","unstructured":"Pagano L, Caira M, Candoni A et\u00a0al (2010) Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study. Haematologica 95:644\u2013650","journal-title":"Haematologica"},{"key":"3704_CR9","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1016\/S1470-2045(14)70017-8","volume":"15","author":"Groll","year":"2014","unstructured":"Groll AH, Castagnola E, Cesaro S et\u00a0al (2014) Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation. Lancet Oncol 15:e327\u2013e340","journal-title":"Lancet Oncol"},{"key":"3704_CR10","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1371\/journal.pmed.0050219","volume":"5","author":"Snelders","year":"2008","unstructured":"Snelders E, Lee HA van der, Kuijpers J et\u00a0al (2008) Emergence of azole resistance in aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med 5:e219","journal-title":"PLoS Med"},{"key":"3704_CR11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/ps.3567","volume":"70","author":"Bowyer","year":"2014","unstructured":"Bowyer P, Denning DW (2014) Environmental fungicides and triazole resistance in aspergillus. Pest Manag Sci 70:173\u2013178","journal-title":"Pest Manag Sci"},{"key":"3704_CR12","doi-asserted-by":"crossref","unstructured":"Linden JW van der, Jansen RR, Bresters D et\u00a0al (2009) Azole-resistant central nervous system aspergillosis. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 48:1111\u20131113","DOI":"10.1086\/597465"},{"key":"3704_CR13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.riam.2012.09.002","volume":"30","author":"Mellado","year":"2013","unstructured":"Mellado E, De La Camara R, Buendia B et\u00a0al (2013) Breakthrough pulmonary aspergillus fumigatus infection with multiple triazole resistance in a Spanish patient with chronic myeloid leukemia. Rev Iberoam Micol 30:64\u201368","journal-title":"Rev Iberoam Micol"},{"key":"3704_CR14","doi-asserted-by":"crossref","unstructured":"Steinmann J, Hamprecht A, Vehreschild MJ et\u00a0al (2015) Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany. J\u00a0Antimicrob Chemother 70:1522\u20131526","DOI":"10.1093\/jac\/dku566"},{"key":"3704_CR15","unstructured":"Vehreschild M, Hamprecht A, Adam T et\u00a0al (2014) The epidemiology of invasive aspergillosis and resistance patterns of Aspergillus spp. in Germany \u2013 interim analysis of a multicenter observational study. In: 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Denver\/CO, USA"},{"key":"3704_CR16","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1128\/AAC.05902-11","volume":"56","author":"Spiess","year":"2012","unstructured":"Spiess B, Seifarth W, Merker N et\u00a0al (2012) Development of novel PCR assays to detect azole resistance-mediating mutations of the Aspergillus fumigatus cyp51a gene in primary clinical samples from neutropenic patients. Antimicrob Agents Chemother 56:3905\u20133910","journal-title":"Antimicrob Agents Chemother"},{"key":"3704_CR17","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/j.1469-0691.2008.02099.x","volume":"14","author":"Blum","year":"2008","unstructured":"Blum G, Perkhofer S, Grif K et\u00a0al (2008) A 1-year Aspergillus terreus surveillance study at the University Hospital of Innsbruck: molecular typing of environmental and clinical isolates. Clin Microbiol Infec 14:1146\u20131151","journal-title":"Clin Microbiol Infec"},{"key":"3704_CR18","doi-asserted-by":"crossref","unstructured":"Lass-Florl C, Grif K, Kontoyiannis DP (2007) Molecular typing of Aspergillus terreus isolates collected in Houston, Texas, and Innsbruck, Austria: evidence of great genetic diversity. J\u00a0Clin Microbiol 45:2686\u20132690","DOI":"10.1128\/JCM.00917-07"},{"key":"3704_CR19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12371","volume":"20","author":"Cornely","year":"2014","unstructured":"Cornely OA, Arikan-Akdagli S, Dannaoui E et\u00a0al (2014) ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect 20(Suppl\u00a03):5\u201326","journal-title":"Clin Microbiol Infect"},{"key":"3704_CR20","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/590004","volume":"47","author":"Chamilos","year":"2008","unstructured":"Chamilos G, Lewis RE, Kontoyiannis DP (2008) Delaying amphotericin\u00a0b-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis 47:503\u2013509","journal-title":"Clin Infect Dis"},{"key":"3704_CR21","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/myc.12203","volume":"57","author":"Tacke","year":"2014","unstructured":"Tacke D, Koehler P, Markiefka B, Cornely\u00a0OA (2014) Our 2014 approach to mucormycosis. Mycoses 57:519\u2013524","journal-title":"Mycoses"},{"key":"3704_CR22","doi-asserted-by":"crossref","unstructured":"Varon AG, Nouer SA, Barreiros G et\u00a0al (2014) Superficial skin lesions positive for fusarium are associated with subsequent development of invasive fusariosis. J\u00a0Infect 68:85\u201389","DOI":"10.1016\/j.jinf.2013.08.011"},{"key":"3704_CR23","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/AAC.01445-09","volume":"54","author":"Wiederhold","year":"2010","unstructured":"Wiederhold NP, Najvar LK, Bocanegra R et\u00a0al (2010) Efficacy of posaconazole as treatment and prophylaxis against Fusarium solani. Antimicrob Agents Chemother 54:1055\u20131059","journal-title":"Antimicrob Agents Chemother"},{"key":"3704_CR24","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1128\/AAC.01606-08","volume":"53","author":"Ruiz-Cendoya","year":"2009","unstructured":"Ruiz-Cendoya M, Marine M, Rodriguez MM, Guarro\u00a0J (2009) Interactions between triazoles and amphotericin\u00a0B in treatment of disseminated murine infection by Fusarium oxysporum. Antimicrob Agents Chemother 53:1705\u20131708","journal-title":"Antimicrob Agents Chemother"},{"key":"3704_CR25","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/1469-0691.12409","volume":"20","author":"Nucci","year":"2014","unstructured":"Nucci M, Marr KA, Vehreschild MJ et\u00a0al (2014) Improvement in the outcome of invasive fusariosis in the last decade. Clin Microbiol Infect 20:580\u2013585","journal-title":"Clin Microbiol Infect"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-015-3704-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-015-3704-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-015-3704-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T04:17:42Z","timestamp":1558585062000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-015-3704-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,4]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["3704"],"URL":"https:\/\/doi.org\/10.1007\/s00108-015-3704-1","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,4]]}}}